Skip to main content
UniHealth

Doctor search

Marilyn J Tan, MD

Endocrinology · Stanford

NPI 1770899395

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
19
4 carriers
Offices
2
Since medical school
17 years
Boston University School of Medicine, 2009

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

19 plans · 4 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

19 of 19 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A113366 · Current

Licensed to practise in California · since 2010 · expires 2027-10-31 · Boston University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
  • American Board of Internal Medicine - Internal Medicine

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$184,641

Medicare paid this office $184,641 for 429 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes165$56,645$71
Return visit (30+ min)178$43,675$116
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes85$24,616$106
Long return visit (40+ min)73$19,363$165
Initial hospital care with moderate level of medical decision making at least 75 minutes102$16,585$155
See all 11 services
Every Original Medicare service billed
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes165$56,645$71
Return visit (30+ min)178$43,675$116
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes85$24,616$106
Long return visit (40+ min)73$19,363$165
Initial hospital care with moderate level of medical decision making at least 75 minutes102$16,585$155
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report71$6,379$31
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes49$5,835$117
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's140$3,489$15
Telephone medical discussion with physician, 21-30 minutes12$2,053$121
Return visit (30+ min)14$1,056$70
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's58$814$13

Who their Medicare patients are

429 Original Medicare patients in 2024. Average age 71 · Under 65 14% · 85 and older 8% · Women 50% · Also on Medicaid 34% · Health risk score 2.79. Sicker patients than 9 in 10 peers; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 50% · Coronary heart disease 42% · Heart failure 31% · Atrial fibrillation 28% · Depression 27% · Cancer 24% · COPD 21% · Dementia 16% · Stroke 14%.

The office billed $927,043, Medicare allowed $236,926 and paid $184,641; for 2,277 services of 14 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244292,277712.79$927,043$184,641
20233681,645703.02$713,627$135,003
20223161,387692.48$572,015$105,954
20213491,563702.42$673,953$125,117
20203441,216692.58$468,724$90,806
20193611,316692.27$336,832$104,762
20183371,340692.55$338,417$109,013
20172831,129682.34$303,233$92,418
2016243863692.20$246,241$71,564
2015223865682.41$229,545$65,480
2014111296671.97$66,236$19,323

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 12 services

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes135$46,694$73
Return visit (30+ min)131$21,200$84
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes69$18,978$110
Long return visit (40+ min)74$14,246$126
Initial hospital care with moderate level of medical decision making at least 75 minutes81$13,634$160
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report61$4,797$31
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes34$4,185$120
Return visit (30+ min)36$3,371$82
Long return visit (40+ min)16$2,068$129
Telephone medical discussion with physician, 21-30 minutes15$1,982$83
Telehealth originating site facility fee50$868$17
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report23$619$23

2022: 13 services

Original Medicare services billed in 2022
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes79$28,833$65
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes56$13,109$94
Long return visit (40+ min)62$10,666$125
Return visit (30+ min)89$10,201$78
Long return visit (40+ min)50$9,820$151
Initial hospital care with moderate level of medical decision making at least 75 minutes49$9,739$180
Return visit (30+ min)67$9,183$97
Telehealth originating site facility fee100$2,996$19
Extended patient service without direct patient contact, first hour31$2,863$89
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes22$2,709$123
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report45$2,368$30
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report37$1,748$28
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes11$300$27

2021: 14 services

Original Medicare services billed in 2021
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes88$33,062$66
Return visit (30+ min)145$19,961$85
Long return visit (40+ min)91$14,603$130
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes46$14,510$95
Return visit (30+ min)55$8,577$119
Long return visit (40+ min)33$6,653$166
New patient visit (60+ min)37$6,184$167
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report55$3,556$31
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes24$2,849$119
Telehealth originating site facility fee88$2,597$21
Telephone medical discussion with physician, 21-30 minutes23$2,384$77
Extended patient service without direct patient contact, first hour17$2,179$104
New patient visit (45+ min)18$2,094$116
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report25$1,228$30

2020: 13 services

Original Medicare services billed in 2020
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes89$33,418$67
Return visit (30+ min)103$9,090$64
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes37$8,052$97
Return visit (30+ min)77$7,150$80
Initial hospital care with moderate level of medical decision making at least 75 minutes34$7,012$180
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes44$5,629$128
Long return visit (40+ min)32$4,052$110
Long return visit (40+ min)33$2,675$79
Telephone medical discussion with physician, 21-30 minutes28$2,507$72
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report33$1,745$29
New patient visit (45+ min)17$1,558$92
Extended patient service without direct patient contact, first hour14$1,413$94
Telehealth originating site facility fee53$1,263$21

2019: 14 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes88$34,325$66
Initial hospital care with moderate level of medical decision making at least 75 minutes69$13,398$184
Return visit (30+ min)122$13,269$67
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes34$9,716$94
Long return visit (40+ min)71$8,659$94
Return visit (30+ min)57$5,850$66
Long return visit (40+ min)31$4,089$97
New patient visit (60+ min)23$3,356$146
New patient visit (60+ min)20$3,180$159
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report33$1,883$31
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes13$1,609$124
New patient visit (45+ min)14$1,283$92
Extended patient service without direct patient contact, first hour11$1,074$98
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes13$710$36

2018: 12 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes108$44,059$65
Initial hospital care with moderate level of medical decision making at least 75 minutes80$15,645$182
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes54$10,579$94
Long return visit (40+ min)67$8,283$93
Return visit (30+ min)68$6,764$66
Long return visit (40+ min)44$5,923$93
New patient visit (60+ min)35$5,161$147
Return visit (30+ min)44$3,616$62
New patient visit (60+ min)15$1,859$124
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes13$1,589$122
New patient visit (45+ min)11$1,022$93
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$839$35

2017: 11 services

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes90$34,787$65
Initial hospital care with moderate level of medical decision making at least 75 minutes65$12,509$181
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes45$10,283$93
Long return visit (40+ min)52$6,614$92
Long return visit (40+ min)49$6,372$87
Return visit (30+ min)65$5,972$66
Return visit (30+ min)32$3,683$66
New patient visit (60+ min)26$3,606$139
New patient visit (60+ min)23$3,166$138
New patient visit (45+ min)14$1,283$92
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$734$35

2016: 11 services

Original Medicare services billed in 2016
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes70$21,085$64
Initial hospital care with moderate level of medical decision making at least 75 minutes55$10,635$180
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes48$9,533$91
Long return visit (40+ min)59$8,677$94
Long return visit (40+ min)41$6,446$92
Return visit (30+ min)41$3,712$59
Return visit (30+ min)21$2,553$65
New patient visit (60+ min)12$1,797$150
New patient visit (45+ min)17$1,770$104
New patient visit (60+ min)13$1,688$130
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes17$1,081$35

2015: 11 services

Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes89$22,062$64
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes37$9,680$93
Long return visit (40+ min)50$6,917$97
Return visit (30+ min)63$6,900$66
Initial hospital care with moderate level of medical decision making at least 75 minutes30$5,437$181
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes39$3,271$35
New patient visit (60+ min)23$3,163$138
New patient visit (45+ min)27$2,787$103
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes22$2,611$119
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes17$1,523$80
Short return visit (20+ min)16$728$36

2014: 5 services

Original Medicare services billed in 2014
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes33$5,060$64
Return visit (30+ min)41$3,356$70
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes21$3,192$35
New patient visit (60+ min)20$2,876$144
Long return visit (40+ min)20$2,664$99

Medicaid work

$81,010 in 2024

Medicaid paid $81,010 for 1,333 billed services this clinician did in 2024, up to 38 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)210$26,871
Return visit (30+ min)320$26,148
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES754$25,952
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES49$2,039
Medicaid work by year
20241,333438$81,010
20231,586647$71,254
2022870540$37,643
2021808442$31,633
2020321333$12,887
2019225228$9,199
2018319321$13,487
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES809$26,751
Long return visit (40+ min)326$23,581
Return visit (30+ min)376$17,353
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES48$2,713
Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service)12$512
Telehealth originating site facility fee15$344

2022

Largest Medicaid services in 2022
Long return visit (40+ min)218$15,422
Return visit (30+ min)270$13,096
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES283$5,642
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES40$1,948
Telehealth originating site facility fee59$1,536

2021

Largest Medicaid services in 2021
Return visit (30+ min)358$15,499
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES322$8,507
Long return visit (40+ min)102$6,999
Telehealth originating site facility fee26$629

2020

Largest Medicaid services in 2020
Return visit (30+ min)215$9,843
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES92$1,976
Long return visit (40+ min)14$1,068

2019

Largest Medicaid services in 2019
Return visit (30+ min)211$8,389
Long return visit (40+ min)14$810

2018

Largest Medicaid services in 2018
Return visit (30+ min)162$7,079
Long return visit (40+ min)56$3,563
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES101$2,845

Drugs they prescribed that Part D paid

$2,077,907

Pharmacies billed $2,077,907 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,278) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

795 generic and 1,292 brand-name prescriptions · $2,077,907 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Korlym12$907,645$75,637
Trulicity179$229,812$1,284
Mounjaro175$228,940$1,308
Ozempic117$185,477$1,585
Jardiance116$141,719$1,222
See all 42 drugs
Every Part D drug this clinician prescribed
Korlym12$907,645$75,637
Trulicity179$229,812$1,284
Mounjaro175$228,940$1,308
Ozempic117$185,477$1,585
Jardiance116$141,719$1,222
Rybelsus28$51,220$1,829
Januvia33$26,185$793
Fiasp Flextouch17$20,129$1,184
Tresiba Flextouch U-20021$17,596$838
Humalog Kwikpen U-20016$17,497$1,094
Basaglar Kwikpen U-10029$17,033$587
Humalog Kwikpen U-10053$13,848$261
Tresiba Flextouch U-10017$11,944$703
Insulin Aspart Flexpen26$10,100$388
Nano 2nd Gen Pen Needle54$8,539$158
Novolog Mix 70-30 Flexpen30$6,343$211
Novolog Flexpen32$6,336$198
Lantus Solostar46$5,641$123
Testosterone11$5,240$476
Tirosint15$4,952$330
Synthroid50$4,834$97
Ultra-Fine Mini Pen Needle43$4,255$99
Insulin Lispro Kwikpen U-10019$3,871$204
Thyquidity11$2,948$268
Hydrocortisone39$2,946$76
Levothyroxine277$2,805$10
Ultra-Fine Nano Pen Needle17$2,353$138
Ultra-Fine Short Pen Needle13$2,150$165
Comfort Ez Pen Needle24$2,054$86
Novolin 70-30 Flexpen11$1,777$162
Insulin Lispro Protamine Mix11$1,692$154
Droplet Pen Needle11$1,569$143
Insulin Glargine-Yfgn13$1,319$101
Glipizide117$1,279$11
Acarbose16$1,092$68
Metformin150$1,046$7
Metformin Hcl Er78$1,043$13
Glyburide21$1,040$50
Methimazole32$524$16
Alendronate30$290$10
Prednisone11$247$22
Atorvastatin28$187$7

Year by year

Part D prescribing by year
20242,2782350% (0)57%$2,077,907
20232,0872160% (0)52%$1,333,901
20222,2012210% (0)52%$1,338,564
20212,3762490% (0)54%$1,324,197
20202,0572490% (0)53%$932,196
20191,9382570% (0)50%$831,150
20181,7852170% (0)50%$615,541
20171,4671810% (0)51%$460,785
20161,1071400% (0)51%$309,066
20158591080% (0)50%$214,900
2014336860% (0)46%$59,635
2013272700% (0)48%$67,405

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 38 drugs

Part D drugs prescribed in 2023
Trulicity180$351,826$1,955
Jardiance90$138,044$1,534
Novolog Flexpen86$107,782$1,253
Mounjaro66$92,926$1,408
Ozempic46$68,815$1,496
Januvia49$41,569$848
Humalog Kwikpen U-10046$39,786$865
Lantus Solostar48$33,836$705
Humalog Kwikpen U-20015$29,065$1,938
Rybelsus15$26,653$1,777
Humulin R U-500 Kwikpen22$24,293$1,104
Basaglar Kwikpen U-10036$23,142$643
Farxiga13$22,914$1,763
Novolog Mix 70-30 Flexpen23$22,566$981
Insulin Aspart Flexpen33$20,466$620
Tresiba Flextouch U-20021$17,701$843
Tresiba Flextouch U-10018$8,982$499
Novolin 70-30 Flexpen12$6,997$583
Nano 2nd Gen Pen Needle40$6,934$173
Levothyroxine253$4,311$17
Ultra-Fine Short Pen Needle28$3,201$114
Ultra-Fine Mini Pen Needle18$3,126$174
Synthroid27$2,960$110
Ketoconazole11$2,323$211
Glipizide129$2,284$18
Ultra-Fine Nano Pen Needle14$2,113$151
Sure Comfort Pen Needle30$2,020$67
Insulin Glargine-Yfgn11$2,013$183
Comfort Ez Pen Needle19$1,968$104
Metformin178$1,885$11
Hydrocortisone25$1,817$73
Droplet Pen Needle14$1,781$127
Acarbose17$1,754$103
Metformin Hcl Er85$1,510$18
Glyburide16$1,471$92
Alendronate38$494$13
Methimazole15$412$27
Atorvastatin24$349$15

2022: 34 drugs

Part D drugs prescribed in 2022
Trulicity203$370,551$1,825
Novolog Flexpen117$134,289$1,148
Jardiance81$109,741$1,355
Humalog Kwikpen U-10058$72,552$1,251
Lantus Solostar114$67,603$593
Januvia63$61,507$976
Ozempic43$55,754$1,297
Novolog Mix 70-30 Flexpen37$44,740$1,209
Forteo11$41,829$3,803
Rybelsus12$30,119$2,510
Toujeo Solostar15$29,451$1,963
Basaglar Kwikpen U-10054$28,723$532
Humulin R U-500 Kwikpen19$18,803$990
Tresiba Flextouch U-10027$15,028$557
Victoza 3-Pak14$13,997$1,000
Tresiba Flextouch U-20011$10,677$971
Comfort Ez Pen Needle61$6,401$105
Nano 2nd Gen Pen Needle38$5,239$138
Ultra-Fine Short Pen Needle27$4,925$182
Levothyroxine231$4,902$21
Synthroid36$3,710$103
Ultra-Fine Mini Pen Needle15$2,352$157
Glipizide165$2,226$13
Hydrocortisone22$1,937$88
Metformin190$1,861$10
Droplet Pen Needle17$1,858$109
Metformin Hcl Er79$1,821$23
Acarbose17$1,676$99
Glyburide15$1,394$93
Atorvastatin23$533$23
Alendronate56$526$9
Pentips14$512$37
Methimazole13$236$18
Lisinopril13$148$11

2021: 36 drugs

Part D drugs prescribed in 2021
Trulicity242$400,459$1,655
Novolog Flexpen143$148,435$1,038
Lantus Solostar143$97,506$682
Jardiance71$92,315$1,300
Humalog Kwikpen U-10052$49,581$953
Januvia56$48,487$866
Ozempic35$46,553$1,330
Victoza 3-Pak31$34,548$1,114
Novolog Mix 70-30 Flexpen31$28,806$929
Basaglar Kwikpen U-10046$25,576$556
Humalog Kwikpen U-20011$23,259$2,114
Tresiba Flextouch U-10041$21,994$536
Humulin R U-50013$21,841$1,680
Toujeo Solostar16$20,896$1,306
Tradjenta13$19,175$1,475
Humulin R U-500 Kwikpen13$14,293$1,099
Novolog11$14,077$1,280
Humalog Mix 75-25 Kwikpen14$11,536$824
Insulin Lispro Kwikpen U-10024$9,460$394
Comfort Ez Pen Needle57$7,066$124
Ultra-Fine Short Pen Needle44$5,696$129
Levothyroxine233$5,332$23
Nano 2nd Gen Pen Needle45$4,372$97
Synthroid37$3,721$101
Hydrocortisone30$2,759$92
Glipizide192$2,690$14
Ultra-Fine Nano Pen Needle16$2,531$158
Metformin203$2,024$10
Acarbose18$2,021$112
Metformin Hcl Er69$1,675$24
Glyburide14$646$46
Atorvastatin26$626$24
Liothyronine12$611$51
Alendronate51$560$11
Methimazole17$335$20
Lisinopril24$312$13

2020: 34 drugs

Part D drugs prescribed in 2020
Trulicity143$206,508$1,444
Novolog Flexpen150$144,324$962
Victoza 3-Pak81$88,942$1,098
Lantus Solostar108$73,958$685
Januvia55$64,130$1,166
Jardiance36$37,127$1,031
Basaglar Kwikpen U-10037$23,311$630
Humalog Mix 75-25 Kwikpen26$21,854$841
Toujeo Solostar20$21,164$1,058
Humalog Kwikpen U-10019$20,249$1,066
Novolog Mix 70-30 Flexpen23$19,077$829
Cinacalcet15$18,360$1,224
Tresiba Flextouch U-10028$15,403$550
Insulin Lispro Kwikpen U-10013$14,346$1,104
Tresiba Flextouch U-20016$12,521$783
Humulin N Kwikpen11$9,920$902
Ultra-Fine Nano Pen Needle47$6,032$128
Levothyroxine211$5,909$28
Ultra-Fine Short Pen Needle41$5,510$134
Comfort Ez Pen Needle45$4,269$95
Synthroid30$3,126$104
Glipizide166$2,706$16
Ulticare Pen Needle13$2,389$184
Acarbose23$2,099$91
Ultra-Fine Mini Pen Needle15$1,982$132
Hydrocortisone37$1,957$53
Metformin181$1,813$10
Ultracare Pen Needle12$1,453$121
Nano 2nd Gen Pen Needle13$1,316$101
Metformin Hcl Er53$1,255$24
Atorvastatin25$512$20
Methimazole22$488$22
Alendronate39$327$8
Lisinopril27$278$10

2019: 37 drugs

Part D drugs prescribed in 2019
Trulicity100$126,270$1,263
Novolog Flexpen114$102,834$902
Victoza 3-Pak83$85,409$1,029
Lantus Solostar99$57,088$577
Januvia55$54,164$985
Novolog Mix 70-30 Flexpen41$41,987$1,024
Jardiance40$37,226$931
Cinacalcet21$25,814$1,229
Humalog Kwikpen U-10029$22,330$770
Humalog Mix 75-25 Kwikpen29$20,301$700
Tresiba Flextouch U-20016$15,762$985
Tresiba Flextouch U-10026$15,287$588
Toujeo Solostar19$15,206$800
Basaglar Kwikpen U-10037$15,091$408
Novolog17$11,479$675
Lantus17$8,973$528
Levothyroxine225$6,441$29
Glucagon Emergency Kit12$5,987$499
Ultra-Fine Nano Pen Needle51$5,094$100
Ultra-Fine Short Pen Needle42$5,057$120
Synthroid22$2,349$107
Acarbose28$2,039$73
Hydrocortisone30$1,986$66
Comfort Ez Pen Needle20$1,964$98
Metformin165$1,795$11
Glipizide162$1,722$11
Ultra-Fine Mini Pen Needle17$1,303$77
Metformin Hcl Er52$803$15
Atorvastatin28$668$24
Glyburide11$536$49
Unifine Pentips17$527$31
Methimazole17$261$15
Glipizide Er12$232$19
Glimepiride13$219$17
Lisinopril18$155$9
Alendronate17$154$9
Amlodipine Besylate12$61$5

2018: 43 drugs

Part D drugs prescribed in 2018
Novolog Flexpen86$61,668$717
Victoza 3-Pak51$54,249$1,064
Januvia54$51,385$952
Novolog Mix 70-30 Flexpen60$50,988$850
Lantus Solostar96$46,808$488
Humalog Kwikpen U-10055$41,901$762
Humulin R U-500 Kwikpen21$29,033$1,383
Humalog Mix 75-25 Kwikpen37$22,754$615
Toujeo Solostar18$20,809$1,156
Tradjenta17$20,725$1,219
Tresiba Flextouch U-10036$20,531$570
Jardiance14$19,437$1,388
Bydureon14$17,440$1,246
Sensipar17$14,691$864
Trulicity17$13,983$823
Tresiba Flextouch U-20020$12,304$615
Novolog16$11,437$715
Humalog13$10,054$773
Lantus13$6,759$520
Basaglar Kwikpen U-10018$6,059$337
Humulin N Kwikpen12$5,599$467
Levothyroxine192$5,439$28
Levemir Flextouch11$5,282$480
Ultra-Fine Nano Pen Needle52$5,280$102
Ultra-Fine Short Pen Needle30$2,951$98
Synthroid30$2,711$90
Metformin158$1,620$10
Hydrocortisone20$1,181$59
Glipizide117$1,066$9
Acarbose16$923$58
Atorvastatin63$921$15
Unifine Pentips22$888$40
Ultra-Fine Mini Pen Needle14$833$59
Glipizide Er24$467$19
Metformin Hcl Er33$400$12
Sure Comfort12$370$31
Losartan17$291$17
Glyburide11$266$24
Methimazole20$221$11
Amlodipine Besylate24$137$6
Lisinopril22$123$6
Glimepiride12$53$4
Single Use Swab11$22$2

2017: 32 drugs

Part D drugs prescribed in 2017
Lantus Solostar118$53,188$451
Novolog Flexpen68$44,779$659
Victoza 3-Pak50$41,578$832
Humalog Kwikpen U-10048$37,395$779
Januvia29$27,360$943
Humalog Mix 75-25 Kwikpen51$26,404$518
Novolog Mix 70-30 Flexpen23$24,602$1,070
Tradjenta30$21,530$718
Bydureon19$20,747$1,092
Humulin R U-50011$18,633$1,694
Toujeo Solostar24$16,322$680
Humulin R U-500 Kwikpen16$15,820$989
Tresiba Flextouch U-20018$14,581$810
Novolog21$11,626$554
Tresiba Flextouch U-10019$9,988$526
Lantus15$8,645$576
Ultra-Fine Nano Pen Needle39$3,921$101
Levothyroxine129$3,577$28
Synthroid37$2,648$72
Ultra-Fine Mini Pen Needle25$1,673$67
Ultra-Fine Short Pen Needle23$1,618$70
Hydrocortisone30$1,597$53
Metformin Hcl Er34$1,273$37
Metformin128$1,265$10
Glipizide82$847$10
Atorvastatin65$758$12
Methimazole33$395$12
Pen Needles15$359$24
Glimepiride17$183$11
Glipizide Xl15$115$8
Lisinopril16$103$6
Amlodipine Besylate13$98$8

2016: 24 drugs

Part D drugs prescribed in 2016
Lantus Solostar114$46,218$405
Humulin R U-50024$41,331$1,722
Humalog Kwikpen U-10064$37,658$588
Tradjenta41$28,278$690
Januvia27$23,798$881
Novolog Flexpen25$17,397$696
Lantus35$13,694$391
Novolog Mix 70-30 Flexpen19$10,702$563
Toujeo Solostar18$7,899$439
Bd Ultra-Fine Pen Needle75$5,540$74
Humalog19$5,536$291
Novolog18$5,058$281
Levemir Flextouch11$4,504$409
Synthroid46$3,400$74
Metformin Hcl Er20$2,741$137
Levothyroxine72$2,085$29
Metformin79$1,018$13
Hydrocortisone24$998$42
Atorvastatin53$808$15
Glipizide68$794$12
Insulin15$669$45
Methimazole23$423$18
Glipizide Xl12$186$15
Lisinopril20$108$5

2015: 23 drugs

Part D drugs prescribed in 2015
Lantus Solostar69$32,259$468
Novolog Flexpen54$30,434$564
Tradjenta25$23,064$923
Humulin R U-50017$22,983$1,352
Januvia15$13,736$916
Humalog Kwikpen U-10021$13,642$650
Novolog Mix 70-30 Flexpen21$13,439$640
Lantus21$9,644$459
Novolog28$8,707$311
Byetta11$7,518$683
Levemir15$5,323$355
Bd Ultra-Fine Pen Needle53$3,459$65
Tirosint18$2,168$120
Synthroid27$1,861$69
Levothyroxine61$1,776$29
Hydrocortisone30$1,514$50
Metformin Hcl Er13$1,193$92
Metformin73$878$12
Atorvastatin36$578$16
Liothyronine15$483$32
Glipizide39$344$9
Alendronate12$136$11
Lisinopril15$83$6

2014: 8 drugs

Part D drugs prescribed in 2014
Lantus Solostar29$11,536$398
Novolog21$5,441$259
Bd Ultra-Fine Pen Needle19$886$47
Hydrocortisone19$786$41
Levothyroxine37$719$19
Alendronate20$217$11
Glipizide22$192$9
Metformin12$114$9

2013: 7 drugs

Part D drugs prescribed in 2013
Forteo21$22,688$1,080
Lantus15$4,802$320
Novolog14$3,295$235
Insulin15$757$50
Levothyroxine23$416$18
Alendronate27$345$13
Insulin11$255$23

Money from drug and device companies

$12,817 in 2025

Industry payments by year
2025417$8,115$12,817
202455$3,613$3,951
202311$3,400$3,400
202234$1,488$1,676
202022$688$810
2019612None$702

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Vertex PharmaceuticalsNone$7,404
14 payments
  • Travel · 2025-10-29 · $85
  • Meals · 2025-10-29 · $18
  • Meals · 2025-10-29 · $6
  • Meals · 2025-10-29 · $29
  • Travel · 2025-10-29 · $42
  • Travel · 2025-10-29 · $2,695
  • Meals · 2025-10-29 · $31
  • Travel · 2025-10-29 · $74
  • Consulting · 2025-10-29 · $3,000
  • Travel · 2025-10-10 · $195
  • Meals · 2025-10-10 · $23
  • Travel · 2025-10-10 · $822
  • Meals · 2025-10-10 · $37
  • Travel · 2025-10-09 · $348
Novo NordiskNone$5,115
1 payment
  • Consulting · 2025-01-01 · $5,115
DexcomDexcom G6 Transmitter$153
1 payment
  • Meals for Dexcom G6 Transmitter · 2025-10-23 · $153
Sequel Med TechTwiist$145
1 payment
  • Meals for Twiist · 2025-09-15 · $145
See all 17 published payments
Every published payment
Vertex PharmaceuticalsTravel · 2025-10-29None$85
Vertex PharmaceuticalsMeals · 2025-10-29None$18
Vertex PharmaceuticalsMeals · 2025-10-29None$6
Vertex PharmaceuticalsMeals · 2025-10-29None$29
Vertex PharmaceuticalsTravel · 2025-10-29None$42
Vertex PharmaceuticalsTravel · 2025-10-29None$2,695
Vertex PharmaceuticalsMeals · 2025-10-29None$31
Vertex PharmaceuticalsTravel · 2025-10-29None$74
Vertex PharmaceuticalsConsulting · 2025-10-29None$3,000
DexcomMeals · 2025-10-23Dexcom G6 Transmitter$153
Vertex PharmaceuticalsTravel · 2025-10-10None$195
Vertex PharmaceuticalsMeals · 2025-10-10None$23
Vertex PharmaceuticalsTravel · 2025-10-10None$822
Vertex PharmaceuticalsMeals · 2025-10-10None$37
Vertex PharmaceuticalsTravel · 2025-10-09None$348
Sequel Med TechMeals · 2025-09-15Twiist$145
Novo NordiskConsulting · 2025-01-01None$5,115
See earlier years (2024, 2023, 2022, 2020, 2019)

2024: $3,951

Payments by company in 2024
Novo NordiskNone$3,613
1 payment
  • Consulting · 2024-01-01 · $3,613
Beta BionicsIlet Bionic Pancreas$164
1 payment
  • Meals for Ilet Bionic Pancreas · 2024-05-28 · $164
Abbott LaboratoriesFreestyle Libre 3$121
1 payment
  • Meals for Freestyle Libre 3 · 2024-01-29 · $121
DexcomDexcom G6 Transmitter$33
1 payment
  • Meals for Dexcom G6 Transmitter · 2024-05-01 · $33
EMD SeronoMavenclad$20
1 payment
  • Meals for Mavenclad · 2024-10-11 · $20

2023: $3,400

Payments by company in 2023
Novo NordiskNone$3,400
1 payment
  • Consulting · 2023-01-20 · $3,400

2022: $1,676

Payments by company in 2022
Novo NordiskNone$1,488
1 payment
  • Consulting · 2022-08-04 · $1,488
Lilly USAMounjaro$127
2 payments
  • Meals for Mounjaro · 2022-07-14 · $116
  • Education · 2022-06-21 · $12
Eiger BiopharmaceuticalsZokinvy$61
1 payment
  • Meals for Zokinvy · 2022-06-11 · $61

2020: $810

Payments by company in 2020
Bayer HealthCare PharmaceuticalsNon-Covered$688
1 payment
  • Paid to speak or teach for Non-Covered · 2020-02-14 · $688
AmgenRepatha$122
1 payment
  • Meals for Repatha · 2020-01-27 · $122

2019: $702

Payments by company in 2019
Novo NordiskOzempic$237
4 payments
  • Meals for Ozempic · 2019-12-03 · $123
  • Meals · 2019-06-17 · $21
  • Meals · 2019-06-07 · $76
  • Meals · 2019-06-07 · $18
Boehringer Ingelheim PharmaceuticalsJardiance$171
2 payments
  • Meals for Jardiance · 2019-10-22 · $83
  • Meals for Jardiance · 2019-06-12 · $88
Tandem Diabetes CareT-Slim Insulin Pump$140
2 payments
  • Meals for T-Slim Insulin Pump · 2019-06-14 · $1
  • Meals for T-Slim Insulin Pump · 2019-06-05 · $139
MannkindAfrezza$127
2 payments
  • Meals for Afrezza · 2019-04-08 · $8
  • Meals for Afrezza · 2019-03-14 · $119
Medtronic MiniMedMinimed 670g System$15
1 payment
  • Meals for Minimed 670g System · 2019-04-16 · $15
InsuletOmnipod$13
1 payment
  • Meals for Omnipod · 2019-11-21 · $13

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1770899395
Licence
CA A113366California A113366: Current · expires 2027-10-31
Trained
Boston University School of Medicine, 2009 · 17 years ago
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2010-08-19
NPI last updated
2024-04-17
NPI record certified
2024-04-17

This is when the NPI record was last certified, not a medical board exam.